Dynamic susceptibility contrast-enhanced echo-planar imaging of cerebral gliomas: Effect of contrast medium extravasation

Authors: E011011011011011011ssig, M.1; W011011011011011011enz, F.1; S011011011011011011choldei, R.1; B011011011011011011rüning, R.2; B011011011011011011erchtenbreiter, C.2; M011011011011011011eurer, M.3; K011011011011011011nopp, M. V.1

Source: Acta Radiologica, 1 July 2002, vol. 43, no. 4, pp. 354-359(6)


Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.


Abstract Purpose:

To assess the influence of the degree of contrast medium extravasation on different DSC EPI MR sequences for perfusion MR imaging. Material and Methods:

60 patients with cerebral gliomas were examined by either an FID EPI or an SE EPI DSC MR sequence. The acquired images were evaluated on a qualitative and quantitative basis. For qualitative assessment, the homogeneity of the signal time curve, image artifacts, the degree of signal drop and the degree of enhancement were evaluated. The quantitative assessment included the percentage of signal drop and the contrast-to-noise ratio of the different EPI sequences was analyzed. Results:

FID EPI presented a more homogeneous signal time curve and a more pronounced susceptibility effect than the SE EPI sequence. Due to the lesser susceptibility effect, the SE EPI sequence was not as sensitive to contrast media extravasation. The signal returned to baseline in all patients. In patients with strongly enhancing lesions, the FID EPI sequence suffered from considerable T1 effects, causing problems in the quantification of perfusion data. Conclusion:

FID EPI sequences were preferred for perfusion MR imaging in patients without strong enhancing lesions, e.g. in ischemia or tumors with intact blood-brain barrier. In patients with suspected strong enhancing lesions, an SE EPI sequence should be used.

Keywords: Brain tumors; blood-brain barrier; perfusion MR imaging

Document Type: Research Article

DOI: http://dx.doi.org/10.1034/j.1600-0455.2002.430402.x

Affiliations: 1: Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg 2: Department of Radiology, Klinikum Grosshadern, München 3: Nycomed Amersham Imaging, Ismaning, Germany.

Publication date: July 1, 2002


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page